Abstract: Previous basic, clinical, and population sciences have advanced the modern treatment of heart failure. An approach to solve this crucial issue is the further development of novel therapeutic strategies based on a novel insight into the pathophysiology of myocardial remodeling and failure. Recent experimental and clinical studies have suggested that oxidative stress is enhanced in heart failure. The production of oxygen radicals is increased in the failing heart whereas antioxidant enzyme activities are preserved in the normal heart. Mitochondrial electron transport is an enzymatic source of oxygen radical generation and also a target against oxidant-induced damage. Chronic increases in oxygen radical production in the mitochondria can lead to a catastrophic cycle of mitochondrial DNA damage as well as functional decline, further oxygen radical generation, and cellular injury. These cellular events might play an important role in the development and progression of myocardial remodeling and failure. Therefore, mitochondrial oxidative stress and DNA damage are good therapeutic targets. This approach may lead to establish the novel and most effective treatment strategies for patients with heart failure.
INTRODUCTION
Congestive heart failure (HF) is a leading cause of morbidity and mortality in industrialized countries [1] . It is also a growing public health problem, mainly because of aging of the population and the increase in the prevalence of HF in the elderly. Previous basic, clinical, and population sciences have advanced the modern treatment of HF. Despite extensive studies, the fundamental mechanisms responsible for the development and progression of left ventricular (LV) failure have not yet been fully elucidated. An important and effective approach to solve this crucial issue is the further development of therapeutic strategies based on a novel insight into the pathophysiology of myocardial remodeling and failure.
Reactive oxygen species (ROS) such as superoxide anions (·O2 -) and hydroxy radicals (·OH) cause the oxidation of membrane phospholipids, proteins, and DNAs [2] and have been implicated in a wide range of pathological conditions including ischemia-reperfusion injury, [3] neurodegenerative diseases, [4] and aging [5] . Under physiological conditions, their toxic effects can be prevented by such scavenging enzymes as superoxide dismutase (SOD), glutathione peroxidase (GSHPx), and catalase as well as by other non-enzymatic antioxidants. However, when the production of ROS becomes excessive, oxidative stress might have a harmful effect on the functional and structural integrity of biological tissue. ROS cause contractile failure and structural damage in the myocardium. The importance of oxidative stress is increasingly emerging with respect to a *Address correspondence to this author at the Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo, 060-8638, Japan; Tel: +81-11-706-6970; Fax: +81-11-706-7874; E-mail: htsutsui@med.hokudai.ac.jp pathophysiological mechanism of left ventricular (LV) remodeling and failure responsible for HF progression.
OXIDATIVE STRESS IN THE FAILING HEARTS
Recent experimental and clinical investigations have suggested the generation of ROS to increase in chronic HF. [6] [7] [8] [9] Lipid peroxides and 8-iso-prostaglandin F2α, which are the major biochemical consequences of ROS generation, have been shown to be elevated in plasma and pericardial fluid of patients with HF and also positively correlated to the severity of HF [6, 7] . However, all of these findings have provided only indirect evidence of ROS generation in the failing hearts. It is difficult to quantify the amount of ROS in the intact biological system since they are unstable and rapidly react with unoxidized adjacent molecules and thus their half life is very short. The only method to directly quantify ROS in biological tissue is electron spin resonance (ESR) spectroscopy. Using ESR combined with the nitroxide radical, 4-hydroxy-2,2,6,6-tetramethyl-piperidine-N-oxyl (hydroxy-TEMPO), as a spin probe, we first provided a definitive and direct demonstration of enhanced generation of ROS in the failing myocardium [10] . ·O2 -is a primary radical that could lead to the formation of other ROS, such as H2O2 and ·OH, in the failing myocardium. ·OH could arise from electron exchange between ·O2 -and H2O2 via the Harber-Weiss reaction. In addition, ·OH is also generated by the reduction of H2O2 in the presence of endogenous iron by means of the Fenton reaction. The generation of ·OH implies a pathophysiological significance of ROS in HF since ·OH radicals are the predominant oxidant species causing cellular injury.
The decreased antioxidant capacity could further aggravate the ROS accumulation in HF. However, the activities of SOD, catalase, and GSHPx were not decreased in the failing hearts [11] . These results thus indicate that oxidative stress in HF is primarily due to the enhancement of prooxidant generation rather than to the decline in antioxidant defenses. Moreover, the generation of ROS is greater than the scavenging capacity of endogenous antioxidants within the failing myocardium.
MECHANISMS OF OXIDATIVE STRESS IN HF
Possible cellular sources of ROS generation within the heart include cardiac myocytes, endothelial cells, and neutrophils. Within cardiac myocytes, ROS can be produced by several mechanisms including mitochondrial electron transport, NADPH oxidase, and xanthine dehydrogenase/ xanthine oxidase. Mitochondria produce ROS through one electron carriers in the respiratory chain. Under physiological conditions, small quantities of ROS are formed during mitochondrial respiration, which, however, can be detoxified by the endogenous scavenging mechanisms of myocytes.
·O2 -can be assessed by using ESR spectroscopy with 5,5'-dimethyl-1-pyrroline-N-oxide (DMPO) as a spin trap, a standard method to detect ROS in the biological tissue. The inhibition of electron transport at the sites of complex I and complex III in the normal submitochondrial particles results in a significant production of ·O2 - [12] . HF mitochondria produce more ·O2 -than normal mitochondria in the presence of NADH, but not succinate as a substrate, indicating that complex I is the predominant source of such ·O2 -production ( Fig. 1 and 2) . Furthermore, HF mitochondria are associated with a decrease in complex I activity. Therefore, mitochondria are the predominant source of ROS in failing hearts, indicating a pathophysiological link between mitochondrial dysfunction and oxidative stress [13] as has been reported in other disease conditions including aging and neurodegenerative diseases.
Even though mitochondrial electron transport is considered to play an important role in the ROS production in HF, we could not completely exclude the possibility that other enzymatic sources of ROS generation such as vascular endothelial cells (via xanthine oxidase and/or NADPH oxidase) and activated leukocytes (via NADPH oxidase) could also contribute to oxidative stress in HF [14] . In fact, Bauersachs et al have demonstrated that vascular NAD(P)H oxidase is activated in HF [15] . This enzyme system is the major source of ROS in both the endothelium and vascular smooth muscle. They are able to generate ROS in response to angiotensin II, which stimulates the expression of NAD(P)H oxidase. Plasma renin activity as well as tissue ACE activity is activated in HF. Therefore, an enhanced formation of angiotensin II may lead to oxidative stress via this enzyme system in HF.
CONSEQUENCES OF OXIDATIVE STRESS IN HF
Oxidative Stress and Mitochondrial DNA Damage ROS can damage mitochondrial macromolecules either at or near the site of their formation. Therefore, in addition to the role of mitochondria as a source of ROS, the mitochondria themselves can be damaged by ROS.
Mitochondria contain closed circular, double-strand DNA of ~16.5 kb. Both strands of the mitochondrial DNA (mtDNA) are transcribed. The mitochondrial genome encodes 13 polypeptides involved in oxidative phosphorylation, including 7 subunits (ND1, ND2, ND3, ND4, ND4L, ND5, and ND6) of rotenone-sensitive NADH-ubiquinone oxidoreductase (complex I), 1 subunit (cytochrome b) of ubiquinol-cytochrome c oxidoreductase (complex III), 3 subunits (COI, COII, and COIII) of cytochrome-c oxidase (complex IV), and 2 subunits (ATPases 6 and 8) of complex V along with 22 tRNAs and 2 rRNA (12S and 16S) subunits (Fig. 3) . The polypeptides are translated by mitochondrial ribosomes and consist of components of the electron transport chain.
The mtDNA could be a major target for ROS-mediated damage for several reasons. First, mitochondria do not have a complex chromatin organization consisting of histone proteins, which may serve as a protective barrier against ROS. Second, mtDNA has a limited repair activity against DNA damage. Third, a large part of ·O2 -which is formed inside the mitochondria can not pass through the membranes and, hence, ROS damage may be contained largely within the mitochondria. In fact, mtDNA accumulates significantly higher levels of the DNA oxidation product, 8-hydroxydeoxyguanosine, than nuclear DNA [16] . As opposed to nuclear-encoded genes, mitochondrial-encoded gene expression is largely regulated by the copy number of mtDNA [17] . Therefore, mitochondrial injury is reflected by mtDNA damage as well as by a decline in the mitochondrial RNA (mtRNA) transcripts, protein synthesis, and mitochondrial function [18, 19] . We have recently shown that the increased generation of ROS was associated with mitochondrial damage and a dysfunction in the failing hearts, which were characterized by an increased lipid peroxidation in the mitochondria, a decreased mtDNA copy number, a decrease in the number of mtRNA transcripts, and a reduced oxidative capacity due to low complex enzyme activities [20] . Chronic increases in ROS production are associated with mitochondrial damage and dysfunction which thus can lead to a catastrophic cycle of mitochondrial functional decline, further ROS generation, and cellular injury (Fig. 4) . MtDNA defects may thus play an important role in the development and progression of myocardial remodeling and failure.
Several possible factors might be involved as the stimuli for increased ROS in HF. The activation of neurohumoral factors commonly seen in HF, including catecholamines and cardiac sympathetic tone, renin-angiotensin system, cytokines, and nitric oxide (NO), can all contribute to the generation of ROS. If mitochondria are the principle source of ROS in response to cytokines such as TNFα and NO, such stimuli may directly modify mitochondrial electron transport function and lead to ·O2-production. Generation of ROS, mtDNA decline, and loss of complex activity could be observed also in vitro when cardiac myocytes were exposed to TNFα [21] . The equivalent results observed between in vivo and in vitro indicate that TNFα plays an important role in oxidative stress in the pathogenesis of myocardial remodeling and failure. Further, overexpression of TNFα gene induced the increase in ROS production in association with the myocardial contractile dysfunction and structural remodeling in mice [22] . However, the pathophysiological role of TNFα has not yet been established in human heart failure [23] .
A number of pathogenic mtDNA base substitution mutations, such as missense mutations and mtDNA rearrangement mutations (deletions and insertions), have been identified in patients with mitochondrial diseases [24] . An accumulation of the deleted forms of mtDNA in the myocardium frequently results in either cardiac hypertrophy, conduction block, or HF [25] . Furthermore, there is now a consensus view that mutations in mtDNA and abnormalities in mitochondrial function are associated with common forms of cardiac diseases such as ischemic heart disease [26] and dilated cardiomyopathy [27] . In these conditions, however, the strict causal relationships between abnormalities in mtDNA and cardiac dysfunction have yet to be fully elucidated [28] . Even though the mechanisms by which mtDNA damage arises in these conditions have not been clarified, ROS have been proposed to be the primary contributing factor. We have provided direct evidence that mtDNA defects occur not only in a limited small subset of mitochondrial diseases but also in a more common HF phenotype occurring after myocardial infarction (MI). This is further supported by the studies on mice lacking MnSOD which show an accumulation of oxidative damage of mtDNA and electron transport complexes [29] in association with the development of dilated cardiomyopathy [30] .
ROS can cause an oxidative modification of nucleotides, such as 8-oxo-7,8-dihydrodeoxyguanosine triphosphate (8-oxo-dGTP), which can lead to defects in DNA replication. The misincorporation of 8-oxo-dGTP into DNA is prevented by 8-oxo-dGTPase, which hydrolyzes 8-oxo-dGTP into 8-oxo-dGMP. We have demonstrated that 8-oxo-dGTPase was highly expressed in the cardiac myocytes from the post-MI failing hearts, thus suggesting that this enzymatic system preventing oxidative DNA damage may be activated in response to increased oxidative stress [31] .
Oxidative Stress and Myocardial Damage
ROS have direct effects on cellular structure and function and may be integral signaling molecules in myocardial remodeling and failure. ROS result in a phenotype characterized by hypertrophy and apoptosis in isolated cardiac myocytes [32] . ROS have also been shown to activate matrix metalloproteinase (MMP) in cardiac fibroblasts [33] . Myocardial MMP activity is increased in the failing hearts [34, 35] . Further, an MMP inhibitor has been shown to limit early LV dilatation in a murine model of MI [36] . We have shown the significant improvement in the survival after MI in MMP-2 knockout mice, which was mainly attributable to the inhibition of early cardiac rupture and the development of subsequent LV dysfunction [37] .Å@ Because MMP can be activated by ROS [38] , one proposed mechanism of LV remodeling is the activation of MMPs secondary to increased ROS production. Sustained MMP activation might influence the structural properties of the myocardium by providing an abnormal extracellular environment with which the myocytes interact. We have demonstrated that ·OH scavenger, dimethylthiourea, inhibits the activation of MMP-2 in association with the development of LV remodeling and failure [39] . These data raise the interesting possibility that increased ROS after MI can be a stimulus for myocardial MMP activation, which might play an important role in the development of HF.
An HMG-CoA reductase inhibitor, fluvastatin, inhibits the production of MMPs at a concentration as low as 5 µmol/L in vitro [40] . Chronic administration of statin into post-MI mice can improve the survival and inhibit the development of cardiac remodeling and failure [41] . These effects were associated with the attenuation of an increase of myocardial MMPs, MMP-2 and MMP-13, in the noninfarcted LV, the site of ongoing remodeling, in fluvastatin-treated animals [41] .
Oxidative Stress and Skeletal Muscle Dysfunction
Oxidative stress could be the mechanistic basis also for muscle fatigue and reduced exercise tolerance in HF patients [42] . This notion is supported by a positive correlation between ROS and exercise intolerance in these patients [43] . Further, we demonstrated that the production of ROS was increased in the skeletal muscle homogenates obtained from a murine model of HF and increased ROS were identified as ·OH originating from ·O2 -, which was associated with a concomitant increase in the oxidation of lipids [44] . These results are consistent with the previous studies that the oxidative capacity is reduced and O2 utilization is inadequate in skeletal muscle mitochondria from HF patients [45] . Skeletal muscle mitochondria from HF are associated with a decrease in the activities of complex I and complex III [44] . As has been shown in the failing hearts [12] , the defects in electron transfer function may lead to the ROS production. ROS may play an important role in the muscle atrophy commonly seen in HF patients through the induction of apoptosis. In addition, ROS impair myoplasmic Ca 2+ homeostasis and inhibit the oxidative energy production in the mitochondria, both of which may contribute to the muscle contractile dysfunction. An attempt to attenuate oxidative stress would improve, to some extent, the exercise capacity of patients with HF.
NOVEL THERAPEUTIC STRATEGIES OF HF TARGETING OXIDATIVE STRESS
Oxidative stress is now proved to play an important role in the development and progression of myocardial remodeling and failure. Based on this novel paradigm, we expect that novel therapeutic strategies of HF could be developed. A growing body of evidence suggests that antioxidants exert protective and beneficial effects in experimental HF [39, [46] [47] [48] [49] . An antioxidant vitamin E prevented the transition from hypertrophy to failure in the guinea pig model of ascending aortic constriction [47] . In addition, probucol, lipid-lowering as well as potent antioxidant agent, had protective effects against pacinginduced HF [48] and adriamycin-induced cardiomyopathy [49] .
The first line of defense mechanism against ROSmediated cardiac injury comprises several antioxidant enzymes including SOD, catalase, and GSHPx. Among these antioxidants, GSHPx is an important enzyme that performs several vital functions. GSHPx is a key antioxidant which catalyses the reduction of H2O2 and hydroperoxides. It not only scavenges H2O2 but also prevents the formation of other more toxic radicals such as ⋅OH. GSHPx possesses a higher affinity for H2O2 than catalase. Further, it is present in relatively high amounts within the heart especially in the cytosolic and mitochondrial compartments [50] . These lines of evidence imply the primary importance of GSHPx as a defense mechanism within the heart compared to catalase. Moreover, GSHPx is expected to exert greater protective effects against oxidative damage than SOD because greater dismutation of ⋅O2 -by SOD may result in an increase of H2O2. Therefore, compared with SOD or catalase, GSHPx is thought to be more effective in protecting cells, tissues, and organs against oxidative damage [51] . We have recently demonstrated that GSHPx overexpression inhibited the development of LV remodeling and failure after MI (Fig. 5  and 6 ), which might contribute to the improved survival [52] . These findings not only extended the previous observation that employed antioxidants, but also revealed the major role of ROS in the pathophysiology of post-MI remodeling. These effects were associated with the attenuation of myocyte hypertrophy, apoptosis, and interstitial fibrosis [52] . Further, peroxiredoxin (Prx )-3, one of 6 distinct Prx family members identified in mammals which can scavenge H2O2, may also exert protective effects against myocardial oxidative damage because it is specifically located in the mitochondria [53] .
Oxidative stress is involved not only in HF, but also in various cardiovascular diseases including atherosclerosis and hypertension. Therefore, therapeutic strategies to modulate this maladaptive response should definitely become a target for future extensive investigation and therapies designed to interfere with oxidative stress, especially within the mitochondria, could have a broader application.
CONCLUSIONS
To improve the prognosis of patients with HF, novel therapeutic strategies based on a novel insight into the pathophysiology of myocardial remodeling and failure need to be developed. Our approach by regulating mitochondrial oxidative stress may contribute to the establishment of the effective treatment strategies for patients with HF. 
